Articles

Oil prices drift lower as traders fret over Fed, look for catalysts

Oil futures trade lower early Tuesday as traders worry over the outlook for crude demand as the Federal Reserve maintains higher interest rates.

‘Is he trying to bamboozle me?’ My husband wants a divorce after 20 years. He offered his $275,000 401(k) in exchange for our $275,000 house.

“I used my 401(k) for life expenses because doctors found a parasite behind my husband’s eye.”

This chart shows one reason why Biden is struggling with a key demographic

Unemployment has spiked among a demographic that is key to President Joe Biden’s re-election prospects: America’s youth.

Yellen says U.S. wants to diversify, not decouple, from China

Treasury Secretary Janet Yellen said the U.S. is trying to diversify but not decouple from China, a week after a series of new tariffs were introduced.

ASML machines can be disabled if China attacks Taiwan, report says

A published report says sophisticated ASML microchip making equipment being used by Taiwan Semiconductor could be remotely disabled in the event that China attacks Taiwan to regain control of what it says is part of its country.

Supermodel Linda Evangelista’s superluxe NYC penthouse is yours for $9.45 million

At just over 4,000 square feet, the posh pad affords incredible views of both the Hudson River and New York City’s High Line park.

The best and worst cities for people with allergies

April showers bring May flowers, but for the 100 million Americans suffering from allergies, this time of year also delivers an abundance of sneezing, coughing, and watery eyes.

The sporty 2025 Mazda CX-70 plug-in hybrid has a rich interior, Euro luxury

The 2025 Mazda CX-70 is a sporty and stylish 5-passenger midsize SUV with near-lux interior appointments.

Treasury yields dip after rising for three days in a row on Fed rate-cut caution

Bond yields fell early Tuesday as investors eyed another batch of comments from Federal Reserve officials.

AstraZeneca kicks off ‘new era of growth’ with aim to hit $80 billion of sales by 2030

The Anglo-Swedish pharmaceutical company’s CEO Pascal Soriot said the announcement marks the start of a “new era of growth”

GSK says late-stage trials of potential blockbuster asthma drug met their goals

GSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than £3 billion ($3.8 billion) met their goals.

Americans must pay higher taxes if they want to keep a high standard of living

Financial challenges face the next U.S. president — but one candidate’s remedies would be a ‘train wreck.’
1 1,136 1,137 1,138 1,139 1,140 2,309